Ticker

Analyst Price Targets — CHEOY

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
November 11, 2024 5:56 amCraig Wong-PanRBC Capital$332.00$95.65StreetInsider RBC Capital Upgrades Cochlear Ltd. (COH:AU) (CHEOY) to Outperform
October 3, 2024 4:15 amMathieu ChevrierCitigroup$305.00$103.15StreetInsider Citi Upgrades Cochlear Ltd. (COH:AU) (CHEOY) to Neutral

Latest News for CHEOY

CochLear (OTCMKTS:CHEOY) and Sonic Healthcare (OTCMKTS:SKHHY) Financial Review

Sonic Healthcare (OTCMKTS:SKHHY - Get Free Report) and CochLear (OTCMKTS:CHEOY - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk. Risk and Volatility Sonic Healthcare has a beta

Defense World • Mar 4, 2026
CochLear (OTCMKTS:CHEOY) versus Biodesix (NASDAQ:BDSX) Head-To-Head Review

CochLear (OTCMKTS:CHEOY - Get Free Report) and Biodesix (NASDAQ: BDSX - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk. Earnings and Valuation This table compares CochLear and Biodesix"s top-line

Defense World • Jan 2, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for CHEOY.

No Senate trades found for CHEOY.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top